Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
1.Trump: Muslim Migration "Destroying Europe, I'm Not Gonna Let That Happen to The U.S."
2.Swedish Girl Shows Idiocy of Trans-Everythingism
3.IT'S HAPPENING: GOD EMPEROR TRUMP INCOMING!
4.Rob Reiner Embarks On "Trump & His Supporters are Racist" National TV Tour
5.Bobby Knight Schools Snarky Anti-Trump CNN Host John Berman
6.Feminist's Art Exhibit In Copenhagen Hails Brussels & Paris Attackers As 'Martyrs'
7.Japanese Girl Shares Her Perspective On "White Guilt"
8.WATCH: Germans Shut Down Leftist Minister's Pro-Migrant Speech & Chase Him Down In The Streets
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.